Evaxion Biotech Share Price

Evaxion Biotech Sees Positive Data in Covid-19 Vaccine Program Jun. 28102021 124833 1-888-992-3836 Free.

Jd7oq7htyfesxm

Evaxion Biotech market cap is 1152 m.

Evaxion biotech share price

. Free forex prices toplists indices and lots more. Evaxion Biotech AS is an artificial intelligence immunology platform company. IPO News for Evaxion Biotech more. Evaxion Biotech AS NASDAQ.

Price trends tend to persist so its worth looking at them when it comes to a share like Evaxion Biotech AS. Evaxion Biotech AS - ADR Stock Forecast EVAX stock price prediction. On average they expect Evaxion Biotech ASs stock price to reach 2067 in the next twelve months. A high-level overview of Evaxion Biotech AS EVAX stock.

Evaxion Biotech AS American Depositary Share EVAX Nasdaq Listed. Evaxion Biotech AS EVAX stock price charts trades the USs most popular discussion forums. Evaxion Biotech AS ADR NASDAQ. On average Wall Street analysts predict that.

Over the past six months the relative strength of its shares against the market has been -2176. Their forecasts range from 1800 to 2300. EVAX stock price fell 44 during premarket trading after raising 24 million via a discounted share subscription. However this morning the companys share price touched as high as 25.

3 brokers have issued 1 year target prices for Evaxion Biotech ASs shares. At the current price of 653 shares in Evaxion Biotech AS are trading at -16 against their 200 day. Webull offers Evaxion Biotech AS EVAX historical stock prices in-depth market analysis NASDAQ. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools.

Evaxion Biotech AS EVAX has priced its 24M follow-on public offering of 3428571 American Depositary Shares at 700 per ADS each ADS represents one ordinary. NASDAQNRDS jumped 60 to 2886 after the company priced. -025 -303 Oct 20 2021. We have developed our AI-immunology core technology to deeply understand the biological processes relevant for engaging the immune system so we can.

We are an AI-immunology TM platform company decoding the human immune system to discover and develop novel immunotherapies for cancer and infectious diseases. According to the issued ratings of 3 analysts in the last year the consensus rating for Evaxion Biotech AS stock is Buy based on the current 3 buy ratings for EVAX. ET Evaxion Biotech started at buy with 23 stock price target at Ladenburg Thalmann. Evaxion Biotech As share price could stay at 1800 by Mar 2 2022.

Evaxion Biotech AS American Depositary Share EVAX Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets. Evaxion Biotechs stock is trading at a volume of 296 million shares as of 1230 EST. Offer Shares mm 30. The best long-term short-term Evaxion Biotech AS - ADR share price prognosis for 2021 2022.

05 2021 GLOBE NEWSWIRE -- Evaxion Biotech AS NASDAQ. EVAX Evaxion or the Company. View Evaxion Biotech stock share price financial statements key ratios and more at Craft. Price Range 1000 - 1200.

EVAX shares jumped 951 to close at 1268 on Thursday after dropping over 10 on Wednesday. This suggests a possible upside of 1684 from the stocks current price. Get the latest Evaxion Biotech AS - ADR EVAX real-time quote historical performance charts and other financial information to help you make more informed trading and investment decisions. Evaxion Biotech Announces Pricing of 240 Million Follow-on Public Offering.

EVAX shares closed yesterday at 650 down 34 on the year. 3 2021 at 829 am. It uses proprietary AI technology engineering expertise and drug development know-how to simulate the human immune system and generate predictive models to identify and develop efficacious immunotherapies for patients in the global market. The average twelve-month price target for Evaxion Biotech AS is 2067 with a high price target of 2300 and a low price target of 1800.

The average Evaxion Biotech A stock price prediction forecasts a potential downside of NA from the current EVAX share price of 792. Depositary Receipt Common Stock Securities Offered. Evaxion Biotech AS has completed an IPO in the amount of 30 million. As covered in this article the biotech company which rose 236 during premarket trading yesterday saw its shares fall following the discounted bookbuild.

Gainers Evaxion Biotech AS NASDAQEVAX shares climbed 179 to 1817 after dropping over 10 on WednesdayNerdWallet Inc. EVAX real-time stock quote data in-depth charts and a fully built financial calendar to. Evaxion Biotech - Investor Relations. Evaxion Biotech AS has completed an IPO in the amount of 30 million.

Data is currently not available. American Depositary Shares Security Type. The exact reason for the massive jump isnt clear. PETZ jumped 798 to.

X2hn6 Edpibuvm